Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rinat Neuroscience CorpfiledCriticalRinat Neuroscience Corp
Publication of CR8883ApublicationCriticalpatent/CR8883A/en
Se describen un annticuerpo monoclonal 9TL y anticuerpos obtenidos de 9TL dirigidos contra peptido beta-amiliode y procedimientos para usar los mismos para el diagnostico y tratamiento de la enfermedad de Alzheimer y enfermedades asociadas a peptido AB.Tambien se describen procedimientos para usar anticuerpos dirigidos contra peptido amiloide-beta que tienen la funcion efectora alterada para el tratamiento de la enfermedad de Alzheimer y enfermedades asociadas a peptido ABA 9TL monoclonal antibody and antibodies obtained from 9TL directed against beta-amiliode peptide and methods for using them for the diagnosis and treatment of Alzheimer's disease and diseases associated with AB peptide are also described. Methods for using antibodies directed against peptide are also described. amyloid-beta that have impaired effector function for the treatment of Alzheimer's disease and diseases associated with AB peptide
CR8883A2004-07-302007-01-29
DIRECTED ANTIBODIES AGAINST BETA-AMYLOID PEPTIDE AND PROCEDURES USING THE SAME
CR8883A
(en)